Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Kwang Sig Lee 1 Article
Usefulness of Diffusion-Weighted MRI for Differentiation between Parkinson’s Disease and Parkinson Variant of Multiple System Atrophy
Eun Joo Chung, Eung Gyu Kim, Jong Seok Bae, Choong Ki Eun, Kwang Sig Lee, Minkyung Oh, Sang Jin Kim
J Mov Disord. 2009;2(2):64-68.
DOI: https://doi.org/10.14802/jmd.09017
  • 12,095 View
  • 73 Download
  • 14 Crossref
AbstractAbstract PDF
Background and Purpose:

Several studies have reported that diffusion-weighted imaging (DWI) is able to help discriminate a Parkinson variant of multiple system atrophy (MSA-p) from Parkinson’s disease (PD) on the basis of the increased regional apparent diffusion coefficient (rADC). We analyzed the usefulness of DWI by using the rADC for differential diagnosis between MSA-p and PD and investigated the correlation between the rADC value and clinical features of MSA-p and PD.

Methods:

Twelve patients with PD and 10 with MSA-p were studied. The rADC value was determined in different brain regions, including the dorsal putamen (DP) and middle cerebellar peduncles (MCP).

Results:

The rADC values of the DP showed a greater increase in MSA-p patients than in PD patients (p=0.03). MSA-p patients also presented increased rADC values of the MCP compared with PD patients (p=0.0001). In particular, the sensitivity, specificity and positive predictive values of the MCP rADC were higher than those of the DP rADC. However, DP and MCP rADC values were not correlated with clinical features in either MSA or PD patients.

Conclusions:

DWI discriminated between PD and MSA-p based on rADC values in DP and MCP. The MCP rADC value, in particular, could better discriminate MSA-p from PD.

Citations

Citations to this article as recorded by  
  • Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review
    Jacopo Pasquini, Michael J. Firbank, Roberto Ceravolo, Vincenzo Silani, Nicola Pavese
    Movement Disorders.2022; 37(10): 1963.     CrossRef
  • Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes
    Germain Arribarat, Patrice Péran
    Current Opinion in Neurology.2020; 33(2): 222.     CrossRef
  • Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer
    Catherine Coolens, Brandon Driscoll, Warren Foltz, Igor Svistoun, Noha Sinno, Caroline Chung
    The British Journal of Radiology.2019; 92(1096): 20170461.     CrossRef
  • “One line”: A method for differential diagnosis of parkinsonian syndromes
    Wataru Sako, Takashi Abe, Shotaro Haji, Nagahisa Murakami, Yusuke Osaki, Yuishin Izumi, Masafumi Harada, Ryuji Kaji
    Acta Neurologica Scandinavica.2019; 140(3): 229.     CrossRef
  • Early stages of Parkinson’s disease: aspects of the diagnosis and therapy
    A. A. Pilipovich
    Medical Council.2019; (18): 61.     CrossRef
  • Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
    Fatemeh N. Emamzadeh, Andrei Surguchov
    Frontiers in Neuroscience.2018;[Epub]     CrossRef
  • Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
    Aron S. Talai, Jan Sedlacik, Kai Boelmans, Nils D. Forkert
    NeuroImage: Clinical.2018; 20: 1037.     CrossRef
  • Magnetic resonance imaging for the diagnosis of Parkinson’s disease
    Beatrice Heim, Florian Krismer, Roberto De Marzi, Klaus Seppi
    Journal of Neural Transmission.2017; 124(8): 915.     CrossRef
  • Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
    Sweta Bajaj, Florian Krismer, Jose-Alberto Palma, Gregor K. Wenning, Horacio Kaufmann, Werner Poewe, Klaus Seppi, Jan Kassubek
    PLOS ONE.2017; 12(12): e0189897.     CrossRef
  • Free-water imaging in Parkinson’s disease and atypical parkinsonism
    Peggy J. Planetta, Edward Ofori, Ofer Pasternak, Roxana G. Burciu, Priyank Shukla, Jesse C. DeSimone, Michael S. Okun, Nikolaus R. McFarland, David E. Vaillancourt
    Brain.2016; 139(2): 495.     CrossRef
  • Imaging synucleinopathies
    David J. Brooks, Nicola Tambasco
    Movement Disorders.2016; 31(6): 814.     CrossRef
  • The difference of apparent diffusion coefficient in the middle cerebellar peduncle among parkinsonian syndromes: Evidence from a meta-analysis
    Wataru Sako, Nagahisa Murakami, Yuishin Izumi, Ryuji Kaji
    Journal of the Neurological Sciences.2016; 363: 90.     CrossRef
  • Imaging-based differential diagnosis between multiple system atrophy and Parkinson's disease
    Wataru Sako, Takashi Abe, Nagahisa Murakami, Yoshimichi Miyazaki, Yuishin Izumi, Masafumi Harada, Ryuji Kaji
    Journal of the Neurological Sciences.2016; 368: 104.     CrossRef
  • Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update
    Giovanni Rizzo, Stefano Zanigni, Roberto De Blasi, Daniela Grasso, Davide Martino, Rodolfo Savica, Giancarlo Logroscino
    Parkinson's Disease.2016; 2016: 1.     CrossRef

JMD : Journal of Movement Disorders